Posted on
Share on Facebook
Share on Twitter
Share on LinkedIn

Pharmaceutical giant GlaxoSmithKline this morning pleaded guilty in U.S. District Court in Boston to two counts of introducing misbranded drugs — Paxil and Wellbutrin — into interstate commerce and one count of failing to report safety data about the drug Avandia to the Food and Drug Administration.

Click here to read more.